Metallic artifacts-free spectral computed tomography angiography based on renal clearable bismuth chelate

• Published in: Biomaterials Vol. 305; p. 122422
• Main Authors: Shu, Gang, Zhao, Lu, Li, Fengtan, Jiang, Yingjian, Zhang, Xuening, Yu, Chunshui, Pan, Jinbin, Sun, Shao-Kai
• Format: Journal Article
• Language: English
• Published: Netherlands 01.03.2024
• Subjects: Bismuth; Contrast agents; Small molecule chelate; Spectral CT; Computed tomography angiograph
• ISSN: 0142-9612; 1878-5905
• DOI: 10.1016/j.biomaterials.2023.122422

Computed tomography angiography (CTA) is one of the most important diagnosis techniques for various vascular diseases in clinic. However, metallic artifacts caused by metal implants and calcified plaques in more and more patients severely hinder its wide applications. Herein, we propose an improved metallic artifacts-free spectral CTA technique based on renal clearable bismuth chelate (Bi-DTPA dimeglumine) for the first time. Bi-DTPA dimeglumine owns the merits of ultra-simple synthetic process, approximately 100% of yield, large-scale production capability, good biocompatibility, and favorable renal clearable ability. More importantly, Bi-DTPA dimeglumine shows superior contrast-enhanced effect in CTA compared with clinical iohexol at a wide range of X-ray energies especially in higher X-ray energy. In rabbits' model with metallic transplants, Bi-DTPA dimeglumine assisted-spectral CTA can not only effectively mitigate metallic artifacts by reducing beam hardening effect under high X-ray energy, but also enables accurate delineation of vascular structure. Our proposed strategy opens a revolutionary way to solve the bottleneck problem of metallic artifacts in CTA examinations.